Mineralys Therapeutics (MLYS) Return on Capital Employed Growth (1y) (2024 - 2026)
Mineralys Therapeutics (MLYS) Return on Capital Employed Growth (1y) (2024 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
31,429.00 |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
16,829.00 |
| 10 |
Mineralys Therapeutics |
1.95 Bn |
1.95 Bn |
- |
4,877.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
4,877.00 |
| Dec 31, 2025 |
5,879.00 |
| Sep 30, 2025 |
2,281.00 |
| Jun 30, 2025 |
-1,866.00 |
| Mar 31, 2025 |
-3,796.00 |
| Dec 31, 2024 |
-5,319.00 |
| Sep 30, 2024 |
-3,952.00 |
| Jun 30, 2024 |
-2,774.00 |
| Mar 31, 2024 |
-1,806.00 |
